| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 3rd March 2021 | Jeffrey E. Eberwein | 1,000 | Open or private purchase | $14.06 | $14,060.00 |
| 1st March 2021 | Jeffrey E. Eberwein | 7 | Open or private purchase | $15.25 | $106.75 |
| 28th February 2021 | Martin B Shirley | 82 | Payment by withholding | $3.38 | $277.16 |
| 28th February 2021 | Matthew G. Molchan | 470 | Payment by withholding | $3.38 | $1,588.60 |
| 28th February 2021 | Matthew G. Molchan | 1,327 | Exercise of derivative | $0.00 | |
| 28th February 2021 | Matthew G. Molchan | 1,049 | Exercise of derivative | $0.00 | |
| 28th February 2021 | Matthew G. Molchan | 372 | Payment by withholding | $3.38 | $1,257.36 |
| 28th February 2021 | Martin B Shirley | 350 | Exercise of derivative | $0.00 | |
| 28th February 2021 | Martin B Shirley | 104 | Payment by withholding | $3.38 | $351.52 |
| 28th February 2021 | Martin B Shirley | 276 | Exercise of derivative | $0.00 |
Digirad Corporation
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.
Digirad Corp. engages in the provision of mobile healthcare solutions. It operates through the following segments: Diagnostic Services, Mobile Healthcare, and Diagnostic Imaging. The Mobile Healthcare segment provides contract diagnostic imaging, including computerized tomography, magnetic resonance imaging, positron emission tomography and healthcare expertise to hospitals. The Diagnostic imaging segment develops solid-state gamma cameras, imaging systems and camera maintenance contracts.
Ticker: DRAD
Sector: Healthcare
Industry: Medical Devices
SEC Central Index Key (CIK): 707388
Employees: 452
Exchange: NASDAQ
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
There were no Red Flags found
Fundamentals
Cash at Carrying Value: $9 M (400%)
Inventory, Net: $8 M (0%)
Other Assets, Current: $1 M (-20%)
Assets, Current: $33 M (11%)
Property, Plant and Equipment, Net: $19 M (0%)
Other Assets, Noncurrent: $997 Th (-14%)
Assets: $89 M (-1%)
Long-term Debt, Current Maturities: $4 M (0%)
Accounts Payable, Current: $6 M (-34%)
Liabilities, Current: $24 M (-13%)
Long-term Debt, Excluding Current Maturities: $19 M (12%)
Other Liabilities, Noncurrent: $1 M (-28%)
Liabilities: $48 M (-4%)
Common Stock, Shares, Issued: $5 M (128%)
Retained Earnings (Accumulated Deficit): $123 M (0%)
Treasury Stock, Value: $57 Th (0%)
Treasury Stock, Shares: $3 M (0%)
Stockholders' Equity (Parent): $21 M (0%)
Liabilities and Equity: $89 M (-1%)
Cost of Revenue: $18 M (-57%)
Gross Margin: $4 M (0%)
Sales and Marketing: $5 M (-56%)
Operating Income/Loss: $2 M (1%)
Other Income, net: $289 Th (1011%)
Provision for income taxes: $50 Th (-40%)
